IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE was reported 1720 times

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN TRACHEAL NEOPLASM 1 0.2000
1 PREICTAL STATE 2 0.1429
2 BRACHYTHERAPY TO PROSTATE 1 0.0833
3 BARREL CHEST 1 0.0526
4 DIURETIC THERAPY 2 0.0278
5 RIGHT ATRIAL PRESSURE INCREASED 2 0.0247
6 CHRONIC THROAT CLEARING 1 0.0227
7 ALCOHOL TEST POSITIVE 1 0.0213
8 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 3 0.0172
9 AORTIC BYPASS 1 0.0154
10 MYCOBACTERIUM TEST POSITIVE 3 0.0146
11 ALCOHOL TEST FALSE POSITIVE 1 0.0106
12 RESPIRATORY FATIGUE 2 0.0086
13 BURKHOLDERIA TEST POSITIVE 1 0.0081
14 INCISION SITE DISCHARGE 2 0.0079
15 BREATH SOUNDS 1 0.0073
16 BRONCHOSPASM PARADOXICAL 2 0.0066
17 PACKAGING DESIGN ISSUE 2 0.0061
18 CARDIOACTIVE DRUG LEVEL DECREASED 1 0.0058
19 COR PULMONALE CHRONIC 1 0.0053
20 ACINETOBACTER BACTERAEMIA 1 0.0053
21 BRONCHIAL IRRITATION 1 0.0052
22 DEAFNESS PERMANENT 1 0.0051
23 CONVULSIVE THRESHOLD LOWERED 2 0.0051
24 PROCEDURAL HEADACHE 2 0.0049
25 BENDOPNOEA 1 0.0045
26 ALLERGY TO PLANTS 2 0.0044
27 CONTINUOUS POSITIVE AIRWAY PRESSURE 1 0.0043
28 CORNEAL NEOVASCULARISATION 1 0.0040
29 ADENOTONSILLECTOMY 1 0.0040
30 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
31 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
32 OXYGEN CONSUMPTION INCREASED 8 0.0033
33 LIQUID PRODUCT PHYSICAL ISSUE 24 0.0033
34 CARBON DIOXIDE ABNORMAL 1 0.0032
35 COR PULMONALE 3 0.0031
36 CONDUCTIVE DEAFNESS 1 0.0031
37 CUBITAL TUNNEL SYNDROME 1 0.0029
38 PRODUCT CLOSURE REMOVAL DIFFICULT 3 0.0029
39 BONE MARROW OEDEMA 3 0.0029
40 ASTHMA EXERCISE INDUCED 1 0.0029
41 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
42 INFUSION SITE MASS 3 0.0028
43 CAPILLARY DISORDER 1 0.0026
44 DEPENDENCE ON RESPIRATOR 1 0.0025
45 POST-TRAUMATIC NECK SYNDROME 2 0.0025
46 DEATH OF RELATIVE 1 0.0025
47 SPUTUM CULTURE POSITIVE 2 0.0025
48 INFUSION SITE OEDEMA 2 0.0024
49 PRODUCT TASTE ABNORMAL 32 0.0024
50 BRONCHIAL SECRETION RETENTION 3 0.0024
51 EOSINOPHILIC PNEUMONIA ACUTE 2 0.0023
52 ANAEMIA OF CHRONIC DISEASE 2 0.0022
53 CIRRHOSIS ALCOHOLIC 1 0.0022
54 RHONCHI 3 0.0022
55 SPUTUM RETENTION 2 0.0020
56 CORNEAL SCAR 1 0.0020
57 PRODUCT MEASURED POTENCY ISSUE 2 0.0020
58 RESPIRATORY TRACT IRRITATION 2 0.0019
59 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
60 BONE DEMINERALISATION 2 0.0019
61 OXYGEN SATURATION ABNORMAL 5 0.0018
62 BURN ORAL CAVITY 1 0.0017
63 CARBON DIOXIDE DECREASED 2 0.0017
64 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
65 COCCIDIOIDOMYCOSIS 2 0.0017
66 CHRONIC RESPIRATORY FAILURE 2 0.0017
67 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
68 BACILLUS INFECTION 1 0.0016
69 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
70 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
71 LIP EXFOLIATION 2 0.0015
72 CATARACT NUCLEAR 1 0.0015
73 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
74 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
75 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
76 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
77 PHARYNGEAL ERYTHEMA 3 0.0014
78 CERVICAL RADICULOPATHY 1 0.0014
79 BRONCHIAL WALL THICKENING 1 0.0014
80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 72 0.0014
81 APALLIC SYNDROME 1 0.0014
82 BACTERIAL DISEASE CARRIER 1 0.0014
83 ACCOMMODATION DISORDER 1 0.0014
84 ATROPHIC VULVOVAGINITIS 1 0.0014
85 INTENTIONAL DEVICE MISUSE 6 0.0014
86 TOBACCO USER 2 0.0013
87 INFUSION SITE REACTION 4 0.0013
88 ASPIRATION PLEURAL CAVITY 1 0.0013
89 INFUSION SITE INFECTION 3 0.0013
90 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 7 0.0013
91 INFUSION SITE PRURITUS 4 0.0013
92 CYSTIC FIBROSIS 7 0.0013
93 PNEUMONIA VIRAL 4 0.0013
94 ALLERGIC GRANULOMATOUS ANGIITIS 1 0.0012
95 OXYGEN THERAPY 2 0.0012
96 SUFFOCATION FEELING 3 0.0012
97 BRONCHIECTASIS 8 0.0012
98 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
99 INCREASED BRONCHIAL SECRETION 3 0.0012
100 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
101 INFUSION SITE DISCHARGE 2 0.0011
102 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
103 CALCIPHYLAXIS 2 0.0011
104 ORAL DISCOMFORT 15 0.0011
105 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
106 SKIN ABRASION 5 0.0011
107 LIP DISORDER 2 0.0011
108 ADRENAL DISORDER 2 0.0010
109 TRAUMATIC LUNG INJURY 2 0.0010
110 NASAL SEPTUM DEVIATION 2 0.0010
111 JOINT NOISE 2 0.0010
112 RESPIRATION ABNORMAL 7 0.0010
113 PRODUCT COLOUR ISSUE 5 0.0010
114 CONJUNCTIVAL OEDEMA 1 0.0010
115 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
116 ALVEOLITIS ALLERGIC 1 0.0010
117 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
118 SPUTUM INCREASED 2 0.0009
119 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
120 CRYPTORCHISM 1 0.0009
121 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
122 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
123 RESPIRATORY TRACT INFECTION 23 0.0009
124 CERVICAL VERTEBRAL FRACTURE 3 0.0009
125 MOUTH SWELLING 5 0.0009
126 ACUTE PRERENAL FAILURE 1 0.0009
127 AORTIC STENOSIS 3 0.0009
128 NECK SURGERY 2 0.0009
129 RIGHT VENTRICULAR FAILURE 6 0.0009
130 LUNG TRANSPLANT 3 0.0008
131 SINUS OPERATION 2 0.0008
132 ACUTE RESPIRATORY FAILURE 16 0.0008
133 PRODUCT PACKAGING CONFUSION 2 0.0008
134 PRODUCTIVE COUGH 39 0.0008
135 DERMAL CYST 2 0.0008
136 BREATH SOUNDS ABNORMAL 4 0.0008
137 HYPOXIA 28 0.0008
138 INFUSION SITE SWELLING 5 0.0008
139 DACRYOSTENOSIS ACQUIRED 1 0.0008
140 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
141 LIPOMA 2 0.0008
142 HERNIA REPAIR 2 0.0008
143 ABDOMINAL OPERATION 1 0.0008
144 ADJUSTMENT DISORDER 1 0.0008
145 RETINAL DISORDER 2 0.0008
146 ANAEMIA POSTOPERATIVE 1 0.0008
147 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
148 ACROCHORDON 1 0.0008
149 OBSTRUCTION 3 0.0008
150 ANION GAP INCREASED 1 0.0007
151 CANDIDIASIS 3 0.0007
152 BODY MASS INDEX INCREASED 1 0.0007
153 DYSGEUSIA 55 0.0007
154 PRODUCT PACKAGING ISSUE 7 0.0007
155 DECUBITUS ULCER 6 0.0007
156 MIGRAINE WITH AURA 2 0.0007
157 PERIPHERAL VENOUS DISEASE 3 0.0007
158 CALCULUS BLADDER 1 0.0007
159 SECRETION DISCHARGE 9 0.0007
160 HEART RATE ABNORMAL 4 0.0007
161 TONGUE DISCOMFORT 3 0.0007
162 SEASONAL ALLERGY 10 0.0007
163 AUDITORY DISORDER 1 0.0007
164 JOINT LOCK 2 0.0007
165 DYSPNOEA AT REST 2 0.0007
166 RALES 4 0.0007
167 STRIDOR 2 0.0007
168 COCCYDYNIA 1 0.0007
169 AXILLARY PAIN 1 0.0007
170 PRODUCT ODOUR ABNORMAL 7 0.0007
171 HYPERCAPNIA 2 0.0007
172 ADHESION 1 0.0007
173 EXPIRED PRODUCT ADMINISTERED 22 0.0007
174 VASCULAR DEVICE INFECTION 3 0.0007
175 ECONOMIC PROBLEM 10 0.0007
176 EMERGENCY CARE 2 0.0007
177 ABDOMINAL HERNIA 3 0.0007
178 SKIN LACERATION 7 0.0006
179 INFUSION SITE EXTRAVASATION 4 0.0006
180 PRE-EXISTING CONDITION IMPROVED 4 0.0006
181 BLOOD CREATININE DECREASED 2 0.0006
182 RESPIRATORY RATE DECREASED 2 0.0006
183 PULMONARY HYPERTENSION 13 0.0006
184 GLAUCOMA 12 0.0006
185 HAEMOGLOBIN ABNORMAL 4 0.0006
186 INFUSION SITE PAIN 8 0.0006
187 RHINITIS 5 0.0006
188 DYSPNOEA EXERTIONAL 23 0.0006
189 INFUSION SITE HAEMORRHAGE 2 0.0006
190 OXYGEN SATURATION DECREASED 34 0.0006
191 ASTHMA 68 0.0006
192 BLOOD CALCIUM ABNORMAL 1 0.0006
193 ARTHROPOD STING 1 0.0006
194 ANXIETY DISORDER 2 0.0006
195 POTENTIATING DRUG INTERACTION 2 0.0006
196 OSTEOPENIA 9 0.0006
197 TOXIC ENCEPHALOPATHY 3 0.0006
198 INSURANCE ISSUE 9 0.0006
199 DEAFNESS BILATERAL 1 0.0006
200 TACHYPNOEA 8 0.0006
201 EAR DISCOMFORT 6 0.0006
202 LEFT VENTRICULAR FAILURE 2 0.0006
203 ACUTE SINUSITIS 1 0.0006
204 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
205 APHONIA 8 0.0006
206 TYPE I HYPERSENSITIVITY 2 0.0006
207 DYSPHONIA 33 0.0006
208 THERMAL BURN 4 0.0006
209 PRODUCT CONTAMINATION 2 0.0006
210 BODY HEIGHT DECREASED 6 0.0006
211 AORTIC VALVE STENOSIS 1 0.0006
212 COMPRESSION FRACTURE 3 0.0006
213 IMPAIRED QUALITY OF LIFE 8 0.0006
214 CHEILITIS 3 0.0006
215 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
216 SCLERODERMA 2 0.0005
217 DENTAL CARIES 6 0.0005
218 HYPERACUSIS 2 0.0005
219 BLOOD CHOLESTEROL DECREASED 1 0.0005
220 BLADDER SPASM 1 0.0005
221 ORAL CANDIDIASIS 7 0.0005
222 WHEEZING 31 0.0005
223 OESOPHAGEAL ULCER 2 0.0005
224 NERVOUSNESS 27 0.0005
225 REHABILITATION THERAPY 2 0.0005
226 ELECTROLYTE IMBALANCE 6 0.0005
227 STRESS CARDIOMYOPATHY 3 0.0005
228 RHINOVIRUS INFECTION 2 0.0005
229 ORAL INFECTION 2 0.0005
230 MULTIPLE ALLERGIES 4 0.0005
231 PROSTATOMEGALY 2 0.0005
232 PNEUMONIA FUNGAL 2 0.0005
233 HOSPICE CARE 5 0.0005
234 POLYDIPSIA 2 0.0005
235 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
236 RESPIRATORY TRACT CONGESTION 8 0.0005
237 HAEMOPTYSIS 14 0.0005
238 CEREBRAL ATROPHY 2 0.0005
239 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
240 EMPHYSEMA 5 0.0005
241 FUNGAL SKIN INFECTION 2 0.0005
242 DRY THROAT 5 0.0005
243 DYSPNOEA 278 0.0005
244 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
245 SPINAL COMPRESSION FRACTURE 4 0.0005
246 FLUID OVERLOAD 7 0.0005
247 INFUSION SITE ERYTHEMA 4 0.0005
248 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
249 BRONCHITIS 35 0.0005
250 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
251 INTERVERTEBRAL DISC DISORDER 2 0.0005
252 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
253 PSEUDOMONAS INFECTION 4 0.0005
254 DEVICE OPERATIONAL ISSUE 2 0.0005
255 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
256 CHOKING 9 0.0005
257 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
258 PULMONARY FUNCTION TEST DECREASED 2 0.0005
259 ACCIDENT AT WORK 1 0.0005
260 CATHETERISATION CARDIAC 2 0.0005
261 IMPLANT SITE PAIN 2 0.0004
262 CORNEAL OEDEMA 1 0.0004
263 SINUS CONGESTION 6 0.0004
264 BLOOD LOSS ANAEMIA 1 0.0004
265 ABNORMAL LOSS OF WEIGHT 3 0.0004
266 URINE ABNORMALITY 2 0.0004
267 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
268 DISEASE COMPLICATION 2 0.0004
269 PNEUMONIA BACTERIAL 4 0.0004
270 EYE OPERATION 2 0.0004
271 LYMPHOEDEMA 3 0.0004
272 NEPHROGENIC ANAEMIA 2 0.0004
273 ARTHRITIS INFECTIVE 2 0.0004
274 RENAL FUNCTION TEST ABNORMAL 2 0.0004
275 ROSACEA 2 0.0004
276 STAPHYLOCOCCAL INFECTION 14 0.0004
277 SPUTUM DISCOLOURED 4 0.0004
278 BACTERAEMIA 5 0.0004
279 FUNGAL INFECTION 14 0.0004
280 MEDICATION RESIDUE PRESENT 2 0.0004
281 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
282 NON-SMALL CELL LUNG CANCER 2 0.0004
283 WRIST FRACTURE 5 0.0004
284 TUMOUR MARKER INCREASED 2 0.0004
285 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
286 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
287 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
288 BREATH ODOUR 1 0.0004
289 BRONCHITIS CHRONIC 1 0.0004
290 HYPERVOLAEMIA 2 0.0004
291 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
292 PULMONARY MASS 6 0.0004
293 BLOOD PRESSURE ABNORMAL 8 0.0004
294 THROAT IRRITATION 18 0.0004
295 CATHETER SITE HAEMORRHAGE 1 0.0004
296 OROPHARYNGEAL PAIN 37 0.0004
297 COUGH 112 0.0004
298 PAROSMIA 3 0.0004
299 CANCER PAIN 1 0.0004
300 RENAL FAILURE CHRONIC 3 0.0004
301 BLOOD CHLORIDE DECREASED 1 0.0004
302 GASTROENTERITIS VIRAL 7 0.0004
303 TRISMUS 2 0.0004
304 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
305 FAILURE TO THRIVE 2 0.0004
306 COMPARTMENT SYNDROME 1 0.0004
307 WEIGHT FLUCTUATION 4 0.0004
308 TRANSFUSION 4 0.0004
309 SENSITIVITY TO WEATHER CHANGE 2 0.0004
310 PULMONARY CONGESTION 5 0.0004
311 HEAD INJURY 12 0.0004
312 NYSTAGMUS 2 0.0004
313 PRODUCT RESIDUE PRESENT 2 0.0004
314 BLOOD SODIUM INCREASED 1 0.0004
315 BACK DISORDER 6 0.0004
316 BACK INJURY 4 0.0004
317 FEELING JITTERY 7 0.0004
318 IMPAIRED GASTRIC EMPTYING 5 0.0004
319 ASPIRATION 4 0.0004
320 PNEUMONIA 118 0.0004
321 GASTROINTESTINAL PAIN 4 0.0004
322 CHOKING SENSATION 2 0.0004
323 PROSTATIC DISORDER 2 0.0004
324 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
325 NASAL CONGESTION 21 0.0004
326 SENSATION OF FOREIGN BODY 3 0.0004
327 EYE INFECTION 4 0.0004
328 SINUS DISORDER 7 0.0004
329 PAIN IN JAW 10 0.0004
330 BRONCHOSPASM 5 0.0004
331 MUSCULOSKELETAL DISCOMFORT 6 0.0003
332 BLOOD MAGNESIUM DECREASED 3 0.0003
333 CARDIAC MURMUR 3 0.0003
334 PRODUCT QUALITY ISSUE 47 0.0003
335 URINE OUTPUT DECREASED 3 0.0003
336 PRODUCT LABEL CONFUSION 2 0.0003
337 RIB FRACTURE 7 0.0003
338 LUNG INFILTRATION 3 0.0003
339 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
340 SINUS HEADACHE 2 0.0003
341 GASTROINTESTINAL INFECTION 3 0.0003
342 HEARING IMPAIRED 2 0.0003
343 GANGRENE 2 0.0003
344 LIP SWELLING 11 0.0003
345 RESTLESS LEGS SYNDROME 6 0.0003
346 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
347 DEVICE FAILURE 5 0.0003
348 CHEST X-RAY ABNORMAL 1 0.0003
349 RESPIRATORY DISTRESS 9 0.0003
350 IRON DEFICIENCY ANAEMIA 3 0.0003
351 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
352 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
353 LUNG INFECTION 5 0.0003
354 FLANK PAIN 3 0.0003
355 ARTERIOSCLEROSIS 3 0.0003
356 ABDOMINAL ADHESIONS 1 0.0003
357 BLADDER PAIN 1 0.0003
358 SLEEP APNOEA SYNDROME 6 0.0003
359 SCIATICA 5 0.0003
360 PROCTALGIA 2 0.0003
361 ATELECTASIS 3 0.0003
362 CARDIAC FLUTTER 2 0.0003
363 DRY MOUTH 25 0.0003
364 VITAMIN D DEFICIENCY 3 0.0003
365 TREMOR 51 0.0003
366 PHARYNGEAL SWELLING 3 0.0003
367 THERAPY CHANGE 3 0.0003
368 ANHEDONIA 8 0.0003
369 LIGAMENT SPRAIN 3 0.0003
370 WALKING AID USER 2 0.0003
371 PRODUCT FORMULATION ISSUE 2 0.0003
372 SINUSITIS 31 0.0003
373 INABILITY TO AFFORD MEDICATION 3 0.0003
374 RESPIRATORY FAILURE 22 0.0003
375 BLOOD POTASSIUM DECREASED 9 0.0003
376 CANDIDA INFECTION 5 0.0003
377 WRONG PRODUCT ADMINISTERED 2 0.0003
378 FLUID RETENTION 15 0.0003
379 PRODUCT LABEL ISSUE 2 0.0003
380 SLUGGISHNESS 3 0.0003
381 RHINORRHOEA 19 0.0003
382 CHEST DISCOMFORT 30 0.0003
383 JOINT EFFUSION 2 0.0003
384 BLOOD CREATININE ABNORMAL 1 0.0003
385 MENTAL STATUS CHANGES 8 0.0003
386 FORMICATION 2 0.0003
387 PERIPHERAL SWELLING 44 0.0003
388 SCRATCH 3 0.0003
389 BRONCHIOLITIS 1 0.0003
390 HEAD DISCOMFORT 5 0.0003
391 DIVERTICULUM 2 0.0003
392 RETCHING 6 0.0003
393 AGEUSIA 7 0.0003
394 DECREASED ACTIVITY 3 0.0003
395 LACTIC ACIDOSIS 9 0.0003
396 ASTHMATIC CRISIS 1 0.0003
397 MAJOR DEPRESSION 2 0.0003
398 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
399 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
400 CEREBRAL DISORDER 2 0.0003
401 CHEST PAIN 50 0.0003
402 CONJUNCTIVITIS 5 0.0003
403 CARDIAC DYSFUNCTION 1 0.0003
404 IMMUNODEFICIENCY 4 0.0003
405 GLOSSODYNIA 6 0.0003
406 INTESTINAL PERFORATION 3 0.0003
407 HYPOAESTHESIA ORAL 4 0.0003
408 MITRAL VALVE INCOMPETENCE 3 0.0003
409 URINARY TRACT INFECTION 45 0.0003
410 BLOOD URINE PRESENT 5 0.0003
411 DERMATITIS CONTACT 3 0.0003
412 COMMUNICATION DISORDER 1 0.0003
413 PULMONARY FIBROSIS 5 0.0003
414 PHARYNGEAL OEDEMA 4 0.0003
415 DRUG EFFECT DECREASED 14 0.0003
416 THYROID DISORDER 4 0.0003
417 FOOD ALLERGY 2 0.0003
418 CONCUSSION 2 0.0003
419 SWOLLEN TONGUE 8 0.0003
420 OEDEMA PERIPHERAL 31 0.0003
421 EPISTAXIS 19 0.0003
422 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
423 FURUNCLE 2 0.0003
424 HEART RATE INCREASED 25 0.0003
425 CHOLECYSTITIS 3 0.0003
426 ULCER 4 0.0003
427 MACULAR DEGENERATION 3 0.0003
428 OBESITY 4 0.0003
429 AZOTAEMIA 1 0.0003
430 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
431 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
432 HIP FRACTURE 8 0.0002
433 VISION BLURRED 34 0.0002
434 MYASTHENIA GRAVIS 2 0.0002
435 MUSCLE TIGHTNESS 4 0.0002
436 TASTE DISORDER 5 0.0002
437 BLOOD POTASSIUM INCREASED 4 0.0002
438 POST PROCEDURAL INFECTION 2 0.0002
439 DYSURIA 9 0.0002
440 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
441 ABNORMAL FAECES 2 0.0002
442 TENDON RUPTURE 3 0.0002
443 PHARYNGITIS 3 0.0002
444 ILEUS 3 0.0002
445 DRY EYE 12 0.0002
446 ACCIDENTAL EXPOSURE 1 0.0002
447 EOSINOPHIL COUNT INCREASED 2 0.0002
448 INTESTINAL OBSTRUCTION 9 0.0002
449 EYE PRURITUS 8 0.0002
450 CATARACT 14 0.0002
451 AORTIC VALVE INCOMPETENCE 1 0.0002
452 CARDIAC FAILURE CHRONIC 1 0.0002
453 FACIAL PARALYSIS 2 0.0002
454 RESPIRATORY DISORDER 7 0.0002
455 VITAMIN D DECREASED 2 0.0002
456 MYDRIASIS 3 0.0002
457 ROTATOR CUFF SYNDROME 3 0.0002
458 PRODUCT CONTAINER ISSUE 2 0.0002
459 IRRITABLE BOWEL SYNDROME 5 0.0002
460 INFLUENZA 26 0.0002
461 DYSPHAGIA 22 0.0002
462 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
463 CHAPPED LIPS 1 0.0002
464 BONE CANCER 1 0.0002
465 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
466 BLOOD CREATINE INCREASED 1 0.0002
467 RESPIRATORY RATE INCREASED 2 0.0002
468 LUNG DISORDER 11 0.0002
469 JOINT RANGE OF MOTION DECREASED 3 0.0002
470 QUALITY OF LIFE DECREASED 3 0.0002
471 ILLNESS 23 0.0002
472 SNEEZING 5 0.0002
473 END STAGE RENAL DISEASE 4 0.0002
474 OSTEOPOROSIS 9 0.0002
475 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
476 INTENTIONAL PRODUCT MISUSE 19 0.0002
477 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
478 POLLAKIURIA 9 0.0002
479 PRODUCT DISTRIBUTION ISSUE 2 0.0002
480 ROAD TRAFFIC ACCIDENT 9 0.0002
481 BACTERIAL INFECTION 4 0.0002
482 LEUKAEMIA 2 0.0002
483 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
484 CARDIAC FAILURE CONGESTIVE 17 0.0002
485 RECALLED PRODUCT ADMINISTERED 2 0.0002
486 POST PROCEDURAL COMPLICATION 4 0.0002
487 LOWER LIMB FRACTURE 4 0.0002
488 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
489 ANOSMIA 3 0.0002
490 HERNIA 4 0.0002
491 LOCALISED INFECTION 5 0.0002
492 PRESYNCOPE 5 0.0002
493 NEURALGIA 5 0.0002
494 GASTROENTERITIS 3 0.0002
495 HEPATOMEGALY 2 0.0002
496 VITREOUS FLOATERS 2 0.0002
497 OEDEMA 11 0.0002
498 ABDOMINAL TENDERNESS 1 0.0002
499 PNEUMONIA ASPIRATION 5 0.0002
500 SPINAL FRACTURE 4 0.0002
501 LACRIMATION INCREASED 6 0.0002
502 CORONARY ARTERY DISEASE 6 0.0002
503 BLOOD COUNT ABNORMAL 3 0.0002
504 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
505 EYELID PTOSIS 2 0.0002
506 DRUG LEVEL DECREASED 2 0.0002
507 TOOTH ABSCESS 2 0.0002
508 ATRIAL FIBRILLATION 19 0.0002
509 EYE PAIN 11 0.0002
510 TEMPERATURE INTOLERANCE 2 0.0002
511 UNRESPONSIVE TO STIMULI 5 0.0002
512 SKELETAL INJURY 2 0.0002
513 EXPOSURE VIA SKIN CONTACT 5 0.0002
514 VENTRICULAR EXTRASYSTOLES 2 0.0002
515 EYE DISCHARGE 2 0.0002
516 PANIC ATTACK 7 0.0002
517 BRAIN FOG 3 0.0002
518 MUSCLE SPASMS 35 0.0002
519 FOLLICULITIS 2 0.0002
520 INJECTION SITE DISCOMFORT 2 0.0002
521 ARRHYTHMIA 9 0.0002
522 BLOOD LACTIC ACID INCREASED 1 0.0002
523 JOINT INJURY 4 0.0002
524 SENSORY DISTURBANCE 3 0.0002
525 HEREDITARY ANGIOEDEMA 2 0.0002
526 NASOPHARYNGITIS 34 0.0002
527 LIMB INJURY 5 0.0002
528 PULMONARY THROMBOSIS 2 0.0002
529 CONSTIPATION 40 0.0002
530 DYSPEPSIA 18 0.0002
531 MULTIPLE FRACTURES 3 0.0002
532 SKIN LESION 5 0.0002
533 ASTHENOPIA 1 0.0002
534 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
535 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
536 VIRAL INFECTION 6 0.0002
537 PROCEDURAL PAIN 5 0.0002
538 NERVE INJURY 2 0.0002
539 SEPSIS 20 0.0002
540 PALPITATIONS 21 0.0002
541 CHILLS 21 0.0002
542 WOUND 5 0.0002
543 MALNUTRITION 2 0.0002
544 PULMONARY OEDEMA 8 0.0002
545 ORAL PAIN 4 0.0002
546 CELLULITIS 9 0.0002
547 ANGIOPATHY 1 0.0002
548 SKIN INFECTION 2 0.0002
549 ACUTE PULMONARY OEDEMA 1 0.0002
550 THERAPY NON-RESPONDER 8 0.0002
551 FALL 59 0.0002
552 HEART RATE IRREGULAR 4 0.0002
553 COLECTOMY 1 0.0002
554 CONTUSION 17 0.0002
555 FLATULENCE 10 0.0002
556 INTENTIONAL DOSE OMISSION 5 0.0002
557 SCAB 2 0.0002
558 MICTURITION URGENCY 2 0.0002
559 INTERNAL HAEMORRHAGE 2 0.0002
560 HYPERSOMNIA 5 0.0002
561 NEOPLASM 2 0.0002
562 PRODUCT SUBSTITUTION ISSUE 10 0.0002
563 HYPOKALAEMIA 8 0.0002
564 BLOOD URIC ACID INCREASED 1 0.0002
565 PERICARDIAL EFFUSION 4 0.0002
566 ASTHENIA 65 0.0002
567 DEVICE USE ERROR 6 0.0002
568 GAIT DISTURBANCE 33 0.0002
569 MUSCULOSKELETAL PAIN 9 0.0002
570 DYSSTASIA 5 0.0002
571 BURNING SENSATION 12 0.0002
572 CHRONIC KIDNEY DISEASE 13 0.0002
573 BONE PAIN 10 0.0002
574 SURGERY 10 0.0002
575 COLD SWEAT 3 0.0002
576 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
577 TACHYCARDIA 15 0.0002
578 CATARACT OPERATION 1 0.0002
579 WEIGHT DECREASED 47 0.0002
580 HYPERLIPIDAEMIA 2 0.0002
581 GOUT 3 0.0002
582 BLOOD PRESSURE FLUCTUATION 4 0.0002
583 DIZZINESS 83 0.0002
584 ARTHRITIS 13 0.0002
585 NOCTURIA 2 0.0002
586 PLEURAL EFFUSION 10 0.0002
587 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
588 BACK PAIN 38 0.0002
589 MUSCLE SPASTICITY 2 0.0002
590 CARDIOMEGALY 2 0.0002
591 SMALL INTESTINAL OBSTRUCTION 2 0.0002
592 ABNORMAL WEIGHT GAIN 2 0.0002
593 NECK PAIN 9 0.0002
594 MIDDLE INSOMNIA 3 0.0002
595 BONE DENSITY DECREASED 5 0.0002
596 PAIN IN EXTREMITY 47 0.0002
597 PHOTOPHOBIA 3 0.0002
598 BLOOD SODIUM DECREASED 3 0.0002
599 BLEPHAROSPASM 1 0.0002
600 BRAIN OEDEMA 2 0.0002
601 PRODUCT COMPLAINT 4 0.0002
602 PRODUCT DOSE OMISSION ISSUE 46 0.0002
603 ANOREXIA 2 0.0002
604 ERUCTATION 3 0.0002
605 DIPLOPIA 4 0.0002
606 HAEMORRHOIDS 3 0.0002
607 AMNESIA 10 0.0002
608 PLATELET COUNT INCREASED 2 0.0002
609 PRODUCT DOSE OMISSION 10 0.0002
610 ASPERGILLUS INFECTION 1 0.0002
611 BEDRIDDEN 2 0.0002
612 CORONAVIRUS INFECTION 1 0.0002
613 INFUSION RELATED REACTION 10 0.0002
614 BLOOD PRESSURE DECREASED 10 0.0002
615 CARDIAC FAILURE ACUTE 1 0.0001
616 AGITATION 11 0.0001
617 HYPOTENSION 30 0.0001
618 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
619 CONFUSIONAL STATE 24 0.0001
620 COLITIS ISCHAEMIC 1 0.0001
621 MALAISE 65 0.0001
622 FEEDING DISORDER 3 0.0001
623 THROAT TIGHTNESS 4 0.0001
624 BLINDNESS 6 0.0001
625 FEELING HOT 9 0.0001
626 RASH ERYTHEMATOUS 7 0.0001
627 ACUTE HEPATIC FAILURE 2 0.0001
628 LUNG NEOPLASM MALIGNANT 6 0.0001
629 CORONARY ARTERY OCCLUSION 2 0.0001
630 GASTRIC DISORDER 5 0.0001
631 PERIPHERAL COLDNESS 2 0.0001
632 HYPERSENSITIVITY 27 0.0001
633 UNEVALUABLE EVENT 11 0.0001
634 GASTROINTESTINAL DISORDER 13 0.0001
635 INFECTION 21 0.0001
636 TOOTH LOSS 3 0.0001
637 BLOOD PRESSURE INCREASED 22 0.0001
638 NEOPLASM PROGRESSION 5 0.0001
639 COORDINATION ABNORMAL 2 0.0001
640 MASS 2 0.0001
641 WEIGHT INCREASED 32 0.0001
642 CARPAL TUNNEL SYNDROME 2 0.0001
643 DEFAECATION URGENCY 1 0.0001
644 HEART RATE DECREASED 5 0.0001
645 DEVICE OCCLUSION 2 0.0001
646 SLEEP DISORDER 10 0.0001
647 FATIGUE 110 0.0001
648 DIALYSIS 2 0.0001
649 EATING DISORDER 3 0.0001
650 MUSCULAR WEAKNESS 16 0.0001
651 HEADACHE 88 0.0001
652 LETHARGY 8 0.0001
653 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
654 PRURITUS GENERALISED 3 0.0001
655 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
656 HYPERTENSION 29 0.0001
657 DRUG INEFFECTIVE 180 0.0001
658 ACUTE MYOCARDIAL INFARCTION 4 0.0001
659 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
660 STEVENS-JOHNSON SYNDROME 3 0.0001
661 ABDOMINAL DISTENSION 14 0.0001
662 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
663 SPEECH DISORDER 7 0.0001
664 ANXIETY 38 0.0001
665 DECREASED APPETITE 31 0.0001
666 APHASIA 4 0.0001
667 PRODUCT AVAILABILITY ISSUE 3 0.0001
668 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
669 NEPHROLITHIASIS 6 0.0001
670 BOWEL MOVEMENT IRREGULARITY 1 0.0001
671 SKIN DISCOLOURATION 6 0.0001
672 DEVICE RELATED INFECTION 2 0.0001
673 SYNCOPE 13 0.0001
674 ATRIOVENTRICULAR BLOCK 1 0.0001
675 APNOEA 1 0.0001
676 DEVICE MALFUNCTION 9 0.0001
677 DEHYDRATION 17 0.0001
678 BALANCE DISORDER 11 0.0001
679 AFFECTIVE DISORDER 1 0.0001
680 PRODUCT USE COMPLAINT 2 0.0001
681 HYPOAESTHESIA 19 0.0001
682 ANAPHYLACTIC REACTION 7 0.0001
683 OCULAR HYPERAEMIA 6 0.0001
684 PNEUMOTHORAX 2 0.0001
685 DRUG INTERACTION 20 0.0001
686 BLOOD ALBUMIN DECREASED 1 0.0001
687 MIGRAINE 12 0.0001
688 COVID-19 22 0.0001
689 ATRIAL FLUTTER 1 0.0001
690 CONDITION AGGRAVATED 38 0.0001
691 THROMBOSIS 10 0.0001
692 HYPERHIDROSIS 16 0.0001
693 UNDERDOSE 9 0.0001
694 DYSKINESIA 5 0.0001
695 DEVICE ISSUE 11 0.0001
696 NAUSEA 97 0.0001
697 VENTRICULAR TACHYCARDIA 2 0.0001
698 ACUTE CORONARY SYNDROME 1 0.0001
699 URINARY RETENTION 4 0.0001
700 GAIT INABILITY 4 0.0001
701 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
702 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
703 TYPE 2 DIABETES MELLITUS 4 0.0001
704 OSTEOARTHRITIS 5 0.0001
705 HYPOPHAGIA 3 0.0001
706 THERAPY CESSATION 6 0.0001
707 FEELING ABNORMAL 28 0.0001
708 HAEMATURIA 4 0.0001
709 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
710 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
711 IRRITABILITY 7 0.0001
712 RECTAL HAEMORRHAGE 5 0.0001
713 CARDIAC OPERATION 1 0.0001
714 RASH GENERALISED 3 0.0001
715 HAEMATOMA 3 0.0001
716 MULTI-ORGAN FAILURE 2 0.0001
717 EMOTIONAL DISTRESS 14 0.0001
718 PAIN 71 0.0001
719 ARTHRALGIA 48 0.0001
720 STOMATITIS 7 0.0001
721 DISCOMFORT 7 0.0001
722 LOCAL SWELLING 2 0.0001
723 JOINT STIFFNESS 3 0.0001
724 NEUROTOXICITY 2 0.0001
725 GASTRITIS 3 0.0001
726 PANCREATITIS 6 0.0001
727 VISUAL IMPAIRMENT 14 0.0001
728 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
729 RENAL FAILURE 15 0.0001
730 DRUG ERUPTION 2 0.0001
731 EAR INFECTION 3 0.0001
732 PRODUCT USE ISSUE 21 0.0001
733 DIARRHOEA 72 0.0001
734 FEAR 3 0.0001
735 ANAL INCONTINENCE 1 0.0001
736 RASH PRURITIC 6 0.0001
737 TOOTHACHE 2 0.0001
738 PALLOR 3 0.0001
739 MOOD ALTERED 3 0.0001
740 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
741 TREATMENT NONCOMPLIANCE 6 0.0001
742 RESTLESSNESS 4 0.0001
743 LOSS OF CONSCIOUSNESS 14 0.0001
744 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
745 BRAIN NEOPLASM 1 0.0001
746 TINNITUS 5 0.0001
747 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
748 ABNORMAL DREAMS 3 0.0001
749 HEPATIC STEATOSIS 2 0.0001
750 DEMENTIA 3 0.0001
751 RENAL DISORDER 5 0.0001
752 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
753 SKIN EXFOLIATION 9 0.0001
754 HYPONATRAEMIA 6 0.0001
755 DYSARTHRIA 4 0.0001
756 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
757 FRACTURE 2 0.0001
758 COLITIS 4 0.0001
759 FOOT FRACTURE 2 0.0001
760 GASTRIC ULCER 2 0.0001
761 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
762 MUSCULOSKELETAL DISORDER 2 0.0001
763 RED BLOOD CELL COUNT DECREASED 3 0.0001
764 INCREASED APPETITE 2 0.0001
765 HERPES ZOSTER 6 0.0001
766 EYE IRRITATION 6 0.0001
767 SEROTONIN SYNDROME 2 0.0001
768 AFFECT LABILITY 1 0.0001
769 PRESCRIBED OVERDOSE 2 0.0001
770 DYSTONIA 2 0.0001
771 AUTOIMMUNE DISORDER 1 0.0001
772 KIDNEY INFECTION 2 0.0001
773 BODY TEMPERATURE DECREASED 1 0.0001
774 INSOMNIA 27 0.0001
775 ABDOMINAL DISCOMFORT 17 0.0001
776 URINARY INCONTINENCE 3 0.0001
777 PYREXIA 35 0.0001
778 DISORIENTATION 4 0.0001
779 RASH 44 0.0001
780 HAEMATOCRIT DECREASED 2 0.0001
781 BLADDER DISORDER 1 0.0001
782 BRAIN INJURY 1 0.0001
783 CYTOKINE RELEASE SYNDROME 2 0.0001
784 ANAEMIA 19 0.0001
785 JOINT SWELLING 12 0.0001
786 PRODUCT PHYSICAL ISSUE 2 0.0001
787 INJECTION SITE RASH 3 0.0001
788 HAEMOGLOBIN DECREASED 10 0.0001
789 INJECTION SITE WARMTH 2 0.0001
790 ABDOMINAL PAIN UPPER 20 0.0001
791 LIMB DISCOMFORT 3 0.0001
792 DRUG DOSE OMISSION 16 0.0001
793 RHABDOMYOLYSIS 4 0.0001
794 DRUG-INDUCED LIVER INJURY 3 0.0001
795 MOUTH ULCERATION 2 0.0001
796 MEMORY IMPAIRMENT 13 0.0001
797 ABDOMINAL PAIN 22 0.0001
798 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
799 RENAL FAILURE ACUTE 4 0.0001
800 DEATH 81 0.0001
801 HYPOTHYROIDISM 3 0.0001
802 METABOLIC ACIDOSIS 3 0.0001
803 BREAST PAIN 1 0.0001
804 MOVEMENT DISORDER 3 0.0001
805 HYPOACUSIS 4 0.0001
806 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
807 DEVICE LEAKAGE 4 0.0001
808 SWELLING FACE 6 0.0001
809 BIPOLAR DISORDER 1 0.0001
810 SEPTIC SHOCK 4 0.0001
811 BLOOD CREATININE INCREASED 6 0.0001
812 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
813 ACUTE KIDNEY INJURY 14 0.0001
814 PRODUCT STORAGE ERROR 8 0.0001
815 EYE DISORDER 3 0.0001
816 PRURITUS 35 0.0001
817 ANGIOEDEMA 4 0.0001
818 SKIN DISORDER 3 0.0001
819 VOMITING 42 0.0001
820 RASH PAPULAR 2 0.0001
821 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
822 BLOOD CALCIUM DECREASED 1 0.0001
823 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
824 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
825 ANGER 3 0.0001
826 CHROMATURIA 2 0.0001
827 FLUSHING 9 0.0001
828 CHOLECYSTECTOMY 1 0.0001
829 CARDIAC FAILURE 7 0.0001
830 ADVERSE EVENT 8 0.0001
831 MUSCLE TWITCHING 2 0.0001
832 NIGHTMARE 3 0.0001
833 HAEMORRHAGE 9 0.0001
834 RASH MACULAR 3 0.0001
835 HYPERKALAEMIA 3 0.0001
836 CARDIAC DISORDER 8 0.0001
837 CARDIAC ARREST 7 0.0001
838 COVID-19 PNEUMONIA 1 0.0001
839 BLOOD IRON DECREASED 1 0.0001
840 ATAXIA 1 0.0001
841 THERAPY INTERRUPTED 6 0.0001
842 DEPRESSION 19 0.0001
843 BLOOD GLUCOSE DECREASED 4 0.0001
844 MENTAL IMPAIRMENT 2 0.0001
845 BURSITIS 1 0.0001
846 DRY SKIN 11 0.0001
847 ADRENAL INSUFFICIENCY 1 0.0001
848 HYPERGLYCAEMIA 3 0.0001
849 ILL-DEFINED DISORDER 5 0.0001
850 ENCEPHALOPATHY 2 0.0001
851 ABASIA 2 0.0001
852 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
853 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
854 ABDOMINAL PAIN LOWER 2 0.0001
855 HAEMATEMESIS 2 0.0001
856 ERYTHEMA 16 0.0001
857 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
858 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
859 OFF LABEL USE 67 0.0001
860 SUICIDAL IDEATION 7 0.0001
861 MYALGIA 13 0.0001
862 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
863 PARAESTHESIA 12 0.0001
864 ANKYLOSING SPONDYLITIS 1 0.0001
865 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
866 BREAST CANCER FEMALE 2 0.0001
867 INJECTION SITE PRURITUS 5 0.0001
868 BLOOD GLUCOSE INCREASED 14 0.0001
869 PAIN OF SKIN 2 0.0001
870 DISTURBANCE IN ATTENTION 4 0.0001
871 EXTRA DOSE ADMINISTERED 3 0.0001
872 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
873 NEUROPATHY PERIPHERAL 7 0.0001
874 PNEUMONITIS 2 0.0001
875 INFLUENZA LIKE ILLNESS 6 0.0001
876 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
877 DIVERTICULITIS 2 0.0001
878 FEELING COLD 2 0.0001
879 CARDIO-RESPIRATORY ARREST 3 0.0001
880 URTICARIA 12 0.0001
881 HOSPITALISATION 11 0.0001
882 RENAL IMPAIRMENT 6 0.0001
883 BLOOD TEST ABNORMAL 1 0.0001
884 BLINDNESS UNILATERAL 1 0.0001
885 CEREBROVASCULAR ACCIDENT 12 0.0001
886 RHEUMATOID ARTHRITIS 8 0.0001
887 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
888 MOBILITY DECREASED 5 0.0001
889 ACCIDENTAL UNDERDOSE 1 0.0001
890 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
891 MYOCARDIAL INFARCTION 12 0.0001
892 NEEDLE ISSUE 2 0.0001
893 MUSCULOSKELETAL STIFFNESS 6 0.0001
894 LABORATORY TEST ABNORMAL 2 0.0001
895 CARDIOMYOPATHY 1 0.0001
896 LIVER DISORDER 3 0.0001
897 DISEASE PROGRESSION 8 0.0001
898 RENAL INJURY 2 0.0001
899 COLON CANCER 1 0.0001
900 BONE LOSS 1 0.0001
901 HALLUCINATION 5 0.0001
902 HOT FLUSH 5 0.0001
903 HEPATIC FAILURE 2 0.0001
904 THERAPEUTIC RESPONSE DECREASED 4 0.0001
905 PLATELET COUNT DECREASED 7 0.0001
906 VERTIGO 4 0.0001
907 SKIN IRRITATION 3 0.0001
908 INJECTION SITE PAIN 20 0.0001
909 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
910 EMOTIONAL DISORDER 2 0.0001
911 ANKLE FRACTURE 1 0.0001
912 SOMNOLENCE 13 0.0001
913 BASAL CELL CARCINOMA 1 0.0001
914 CYANOSIS 1 0.0001
915 COMA 3 0.0001
916 CYSTITIS 2 0.0001
917 ABSCESS 1 0.0001
918 DRUG INTOLERANCE 6 0.0001
919 NIGHT SWEATS 2 0.0001
920 INTERSTITIAL LUNG DISEASE 3 0.0001
921 DEEP VEIN THROMBOSIS 4 0.0001
922 INCORRECT DOSE ADMINISTERED 14 0.0001
923 OSTEONECROSIS 2 0.0001
924 NO ADVERSE EVENT 11 0.0001
925 SEIZURE 7 0.0001
926 VISUAL ACUITY REDUCED 2 0.0001
927 LEUKOPENIA 3 0.0001
928 INFLAMMATION 3 0.0001
929 ECZEMA 3 0.0001
930 DERMATITIS ATOPIC 3 0.0001
931 BRADYCARDIA 3 0.0001
932 INJECTION SITE ERYTHEMA 7 0.0001
933 ALOPECIA 11 0.0001
934 PRODUCT ADHESION ISSUE 2 0.0001
935 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
936 CEREBRAL HAEMORRHAGE 2 0.0001
937 ACCIDENTAL OVERDOSE 2 0.0001
938 INJECTION SITE MASS 2 0.0001
939 THROMBOCYTOPENIA 6 0.0001
940 SWELLING 5 0.0001
941 BLISTER 3 0.0001
942 INJECTION SITE SWELLING 4 0.0001
943 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
944 OVERDOSE 11 0.0001
945 DEVICE BREAKAGE 2 0.0000
946 BODY TEMPERATURE INCREASED 1 0.0000
947 WITHDRAWAL SYNDROME 2 0.0000
948 DEVICE DISLOCATION 2 0.0000
949 DEVICE DIFFICULT TO USE 3 0.0000
950 NEOPLASM MALIGNANT 3 0.0000
951 INJECTION SITE REACTION 3 0.0000
952 BLOOD CHOLESTEROL INCREASED 2 0.0000
953 COGNITIVE DISORDER 2 0.0000
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
955 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
956 DISEASE RECURRENCE 2 0.0000
957 SKIN BURNING SENSATION 3 0.0000
958 MULTIPLE SCLEROSIS 2 0.0000
959 HYPOGLYCAEMIA 2 0.0000
960 CEREBRAL INFARCTION 1 0.0000
961 ACNE 3 0.0000
962 CARDIOVASCULAR DISORDER 1 0.0000
963 DIABETES MELLITUS 3 0.0000
964 ANAPHYLACTIC SHOCK 1 0.0000
965 DRUG DOSE OMISSION BY DEVICE 3 0.0000
966 DEAFNESS 1 0.0000
967 BLOOD BILIRUBIN INCREASED 1 0.0000
968 HAEMATOCHEZIA 2 0.0000
969 CONVULSION 2 0.0000
970 ANGINA PECTORIS 1 0.0000
971 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
972 DRUG WITHDRAWAL SYNDROME 3 0.0000
973 ASCITES 1 0.0000
974 ADVERSE DRUG REACTION 3 0.0000
975 PULMONARY EMBOLISM 3 0.0000
976 CHOLELITHIASIS 1 0.0000
977 HEPATIC ENZYME INCREASED 2 0.0000
978 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
979 DELIRIUM 1 0.0000
980 INJURY 2 0.0000
981 CRYING 1 0.0000
982 ABNORMAL BEHAVIOUR 1 0.0000
983 INJECTION SITE BRUISING 2 0.0000
984 PROSTATE CANCER 2 0.0000
985 PSORIASIS 3 0.0000
986 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
987 COLITIS ULCERATIVE 1 0.0000
988 BREAST CANCER 2 0.0000
989 DEPENDENCE 1 0.0000
990 TOXICITY TO VARIOUS AGENTS 3 0.0000
991 NEUTROPENIA 2 0.0000
992 COMPLETED SUICIDE 1 0.0000